VBL Therapeutics announced an organizational streamlining designed to reduce operating expenses and preserve capital. As a result, VBL will reduce its workforce by approximately 35%. As part of the cost cutting initiatives, Dr. Ron Cohen, Dr. Bennett Shapiro and Ms. Alison Finger resigned from the board of directors, effective August 1, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.81 USD | -15.63% | -20.59% | -57.14% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.14% | 7.21M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.28% | 21.78B | |
-9.10% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- NTBL Stock
- News Notable Labs, Ltd.
- VBL Therapeutics Announces Executive Resignations